PlumBot: Bot: Creating new article from JSON

2026-03-18T06:50:16Z

Bot: Creating new article from JSON

New page

📋 '''Cost-benefit analysis (CBA)''' is a decision-making framework that systematically compares the expected costs and benefits of a proposed action, investment, or policy change — and in the insurance industry, it underpins decisions ranging from entering a new line of business to implementing [[Definition:Regulatory technology (regtech) | regtech]] platforms or modifying [[Definition:Claims management | claims]] processes. Insurers and [[Definition:Reinsurer | reinsurers]] operate in environments where capital allocation choices carry significant consequences: deploying resources toward a new [[Definition:Cyber insurance | cyber insurance]] product, for instance, requires weighing development costs, anticipated [[Definition:Loss ratio | loss ratios]], regulatory setup expenses, and projected [[Definition:Premium | premium]] income against the opportunity cost of deploying that capital elsewhere.

⚙️ Conducting a CBA in the insurance context involves quantifying both tangible and intangible factors. Hard costs — such as technology licensing fees, staffing, [[Definition:Reinsurance | reinsurance]] purchase costs, and [[Definition:Compliance requirement | regulatory filing]] expenses — are typically straightforward to estimate. Benefits, however, often require [[Definition:Actuarial analysis | actuarial]] and financial modeling to project premium volumes, [[Definition:Expense ratio | expense ratio]] improvements, or [[Definition:Claims cycle time | claims handling]] efficiencies over a multi-year horizon. Intangible considerations — improved [[Definition:Customer experience | customer satisfaction]], enhanced regulatory standing, or reduced [[Definition:Operational risk | operational risk]] — are harder to monetize but no less important. European insurers operating under [[Definition:Solvency II | Solvency II]] may incorporate the [[Definition:Capital adequacy | solvency capital]] implications of a strategic initiative directly into their CBA, since any new risk assumption or operational change can alter the firm's capital position under the standard or internal model.

💡 Regulators themselves increasingly expect insurers to present cost-benefit evidence when seeking approval for material changes — whether that involves a new product filing in the U.S. state regulatory system, an [[Definition:Outsourcing | outsourcing]] arrangement subject to EIOPA guidelines, or a proposed [[Definition:Internal model | internal model]] change under Solvency II. Beyond regulatory contexts, disciplined use of CBA helps insurance organizations resist the allure of trendy but uneconomic initiatives, ensuring that [[Definition:Insurtech | insurtech]] investments, geographic expansions, or distribution experiments generate returns commensurate with the risks assumed. When performed honestly — accounting for realistic loss scenarios rather than best-case assumptions — a CBA functions as a guardrail against the overconfidence that has historically led insurers into underpriced lines of business.

'''Related concepts:'''
{{Div col|colwidth=20em}}
* [[Definition:Capital allocation]]
* [[Definition:Return on equity (ROE)]]
* [[Definition:Actuarial analysis]]
* [[Definition:Expense ratio]]
* [[Definition:Risk appetite]]
* [[Definition:Strategic planning]]
{{Div col end}}

Definition:Cost-benefit analysis (CBA) - Revision history

PlumBot: Bot: Creating new article from JSON